ICER’s Report on Launch Pricing Falls Short by Emphasizing Questionable Price Data Rather Than Access Barriers
Shares:
There are two weirdly similar stories out today on how to shop thoughtfully for low-priced medicines, one from USA Today and one from the Boston Globe. These two pieces are
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
BENDING YOUR EAR/ Cost Curve Apex Launches Tomorrow Cost Curve Apex -- the premium version of this newsletter -- launches tomorrow with the goal of ensuring I’m providing the best